<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Bernhardt SM</submitter><funding>NCI NIH HHS</funding><pubmed_abstract>Young women have increased risk of vitamin D deficiency, which may increase breast cancer incidence. Here, we assessed the anti-cancer efficacy of vitamin D in mouse models of young-onset breast cancer. In never-pregnant mice, vitamin D supplementation increased serum 25(OH)D and hepatic 1,25(OH)&lt;sub>2&lt;/sub>D&lt;sub>3&lt;/sub>, reduced tumor size, and associated with anti-tumor immunity. These anti-tumor effects were not replicated in a mouse model of postpartum breast cancer, where hepatic metabolism of vitamin D was suppressed post-wean, which resulted in deficient serum 25(OH)D and reduced hepatic 1,25(OH)&lt;sub>2&lt;/sub>D&lt;sub>3&lt;/sub>. Treatment with active 1,25(OH)&lt;sub>2&lt;/sub>D&lt;sub>3&lt;/sub> induced hypercalcemia exclusively in post-wean mice, highlighting metabolic imbalance post-wean. RNAseq rev</pubmed_abstract><journal>bioRxiv : the preprint server for biology</journal><pagination>2024.05.28.596304</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11160686</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Altered liver metabolism post-wean abolishes efficacy of vitamin D for breast cancer prevention in a mouse model.</pubmed_title><pmcid>PMC11160686</pmcid><funding_grant_id>P30 CA069533</funding_grant_id><funding_grant_id>R01 CA169175</funding_grant_id><pubmed_authors>DeBarber AE</pubmed_authors><pubmed_authors>Xia Z</pubmed_authors><pubmed_authors>Schedin P</pubmed_authors><pubmed_authors>Ozaki MK</pubmed_authors><pubmed_authors>Fornetti J</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Bernhardt SM</pubmed_authors><pubmed_authors>Wilde De E</pubmed_authors><pubmed_authors>Bleyle LA</pubmed_authors><pubmed_authors>Betts C</pubmed_authors><pubmed_authors>Liberty AL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Altered liver metabolism post-wean abolishes efficacy of vitamin D for breast cancer prevention in a mouse model.</name><description>Young women have increased risk of vitamin D deficiency, which may increase breast cancer incidence. Here, we assessed the anti-cancer efficacy of vitamin D in mouse models of young-onset breast cancer. In never-pregnant mice, vitamin D supplementation increased serum 25(OH)D and hepatic 1,25(OH)&lt;sub>2&lt;/sub>D&lt;sub>3&lt;/sub>, reduced tumor size, and associated with anti-tumor immunity. These anti-tumor effects were not replicated in a mouse model of postpartum breast cancer, where hepatic metabolism of vitamin D was suppressed post-wean, which resulted in deficient serum 25(OH)D and reduced hepatic 1,25(OH)&lt;sub>2&lt;/sub>D&lt;sub>3&lt;/sub>. Treatment with active 1,25(OH)&lt;sub>2&lt;/sub>D&lt;sub>3&lt;/sub> induced hypercalcemia exclusively in post-wean mice, highlighting metabolic imbalance post-wean. RNAseq rev</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jun</publication><modification>2026-07-05T03:17:04.223Z</modification><creation>2026-07-05T03:12:23.597Z</creation></dates><accession>S-EPMC11160686</accession><cross_references><pubmed>38854129</pubmed><doi>10.1101/2024.05.28.596304</doi></cross_references></HashMap>